- Cosmos Health increases its Ethereum holdings to $1.8 million as part of a $300 million digital asset plan.
- CEO Greg Siokas says the company remains committed to accelerating its crypto acquisitions.
- Shares have risen 200% over six months as Cosmos expands in healthcare and digital finance.
Cosmos Health Inc. (NASDAQ: COSM) has strengthened its position in digital assets by purchasing $300,000 worth of Ethereum (ETH), bringing the healthcare group’s total cryptocurrency holdings to $1.8 million.
Announced Monday, the purchase is part of the company’s broader $300 million digital asset initiative designed to diversify the balance sheet and support long-term growth.
Headquartered in Chicago and active in pharmaceutical manufacturing, distribution, and telemedicine, Cosmos Health has become increasingly engaged with digital assets in recent months.
Cosmos Health shares have jumped nearly 200% over the past six months.
Strategic expansion through digital assets
The latest Ethereum acquisition underscores Cosmos Health’s commitment to integrating digital assets into its broader financial strategy.
“We have continued to increase our Ethereum holdings following last week’s purchase, bringing our total ETH investment to $1.8 million,” said CEO Greg Siokas.
“We remain committed to accelerating our acquisition program under our $300 million credit facility,” he added, emphasizing the company’s intent to broaden its exposure to blockchain-based assets.
The purchase follows a series of prior cryptocurrency investments made under the same program first announced earlier this year.
This initiative reflects Cosmos Health’s diversification approach, balancing core healthcare operations with new opportunities in digital finance and technology.
Founded in 2009 and incorporated in Nevada, Cosmos Health operates across several key healthcare sectors, including nutraceuticals, branded pharmaceuticals, and healthcare distribution.
Its operations extend to Greece and the United Kingdom, with major distribution centers located in Thessaloniki, Athens, and Harlow.
Broader strategic developments
Beyond digital assets, Cosmos Health is advancing corporate and operational initiatives to expand its global footprint.
The company recently announced the appointment of Theodoros K. Karkantzos to its board of directors.
Karkantzos brings more than 15 years of experience in investment and business development and will serve on the Nominating and Corporate Governance Committee.
Additionally, Cosmos Health expanded its Sky Premium Life brand into Kuwait through an exclusive distribution agreement with Diyar United.
Under the agreement, Diyar United will market and distribute the company’s nutraceutical products in Kuwait, further strengthening Cosmos Health’s international reach.
At its most recent annual shareholder meeting, the company also secured approval to increase its authorized shares to 1.5 billion common shares and 300 million preferred shares, a move intended to provide greater financial flexibility.
A diversified path forward
Cosmos Health’s growing engagement with digital assets, particularly Ethereum, highlights a broader trend of traditional companies exploring blockchain integration and crypto investments as part of financial diversification strategies.
While the company’s primary focus remains on healthcare and wellness, its emphasis on digital assets and strategic partnerships signals a forward-looking approach to technology-driven financial management.
With Ethereum investments now totaling $1.8 million and a $300 million capacity available for further expansion, Cosmos Health appears well positioned to balance innovation across healthcare markets and financial markets as it pursues sustainable long-term growth.